Inclusion Criteria:~* Diagnosis of Early AD including evidence of brain amyloidosis by CSF or PET~* MMSE score
≥ 20 points, CDR Global Score of 0.5 - 1.0, and RBANS score on the DMI ≤95.~* Study partner who consents to
study participation and who cares for/visits the participant at least 10 hours a week~* Written informed
consent must be obtained and documented (from the participant or, where jurisdictions allow it, from their
legal decision maker).~
